Evolution Seminar Unit 8 Research Paper Example | Topics and Well Written Essays - 250 words

Evolution Seminar Unit 8 - Research Paper Example When scientists use the term â€Å"theory†, it already has years of research behind it before it has been presented for scientific evaluation. However to a non-scientist theory is something that is â€Å"cutting-edge† science and needs to be taught to the children Antibacterial resistance of bacteria and pesticide resistance are good examples of natural selection. Since resistance is a genetic characteristic, not all bacteria had the gene that would induce resistance against an antimicrobial agent. However, a few bacteria did have resistance against the agent and hence nature â€Å"selected† them for survival. Therefore the later generation too had this gene carried forward to show resistance against the antimicrobial agent and hence evolution occurred. 6 Charles Darwin died before Gregor Mendel, also known as the Father of Genetics, shared his discoveries on the inheritance of traits. However, their research definitely complements one another. How could further research into genetics continue to help us understand the process of evolution? Genetics is today the most important tool in understanding everything about the origin and life of earth as well as that of human beings. Using molecular tools we will be able to understand the origin of man and how exactly we evolved and so on. It is not only man that we can study but also how man and other animals are linked and construct phylogenetic trees more

Business straegies,development and management of Glaxo-Smithcline Essay

Business straegies,development and management of Glaxo-Smithcline - Essay Example Glaxo started as a small firm in 1970s with dried milk business and added antibiotics, nutritional supplements and respiratory drugs. Glaxo Inc was born as a result of acquisition of Meyer Laboratories in the US (Heller, 2006). It started investing in R&D during the 1980s which gave the company a phenomenal growth. By 1994 Glaxo had 3.6 percent share of the world market and had a strong presence in Europe and US (BÃ ¡tiz-Lazo, 2003). Its position as the leader was established in 1994 when the industry as a whole faced increased drug discovery costs. Wellcome Foundation (WF), the largest non-profit drug medical institution in the UK, had an ‘academic’ approach to pharmaceuticals – with strong science but weak in marketing. WF had a 40% stake in Galxo’s Zantac which contributed to 43 percent of Glaxo’s revenues. To a large extent the growth of Glaxo was based on the success of Zantac. Glaxo strategically engineered a takeover of Wellcome as Zantac’s patent was due to expire in 1997 and Wellcome had the capability to dissipate risk and ensure that resources would be able for research. The merger further consolidated Glaxo’s position as the third largest company by market capitalization in London and the world’s largest research firm with 54,000 employees. Organizational culture differences erupted trouble in the merger. While WF had a laid back management style and focused on science, Glaxo had a commercial and control-driven culture. The drugs pipeline was unimpressive and ne w products failed to live up to expectations. This paved the way for the merger of Glaxo Wellcome with SmithKline Beecham at the turn of the century. Glaxo SmithKline (GSK) was formed in December 2000 by the merger of Glaxo Wellcome plc and SmithKline Beecham plc. In 2005, it became the world’s second largest research-based pharmaceutical company in the industry (RedOrbit, 2006). The demand of the market was very high and integration of new people